ALPHA-FETOPROTEIN-PRODUCING UNDIFFERENTIATED CARCINOMA OF THE BLADDER

被引:23
作者
YAMADA, K
FUJIOKA, Y
EBIHARA, Y
KIRIYAMA, I
SUZUKI, H
AKIMOTO, M
机构
[1] NIPPON MED COLL,DEPT UROL,TOKYO,JAPAN
[2] KAWAKITA GEN HOSP,DEPT UROL,TOKYO,JAPAN
[3] KAWAKITA GEN HOSP,DEPT PATHOL,TOKYO,JAPAN
关键词
ALPHA FETOPROTEINS; BLADDER; CARCINOMA; CYSTECTOMY;
D O I
10.1016/S0022-5347(17)32623-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report on a rare primary undifferentiated carcinoma of the bladder producing alpha-fetoprotein in a woman. Definitive features included an aggressive, invasive and rapidly growing tumor with a hepatoid carcinomatous lesion on histological examination. Histopathological findings suggested that the multipotent transitional cell induces production of alpha-fetoprotein. The association of an aggressive tumor with the ability to produce this antigen suggests a possible benefit in measuring serum alpha-fetoprotein levels and examining histological sections for its expression in primary undifferentiated carcinoma of the bladder. Further study may indicate radical cystectomy when the resected specimen produces alpha-fetoprotein, particularly if tumors appear to be aggressive and highly vascularized as in our case.
引用
收藏
页码:958 / 960
页数:3
相关论文
共 10 条
[1]  
BERGSTRAND CG, 1975, SCAND J CLIN LAB INV, V9, P277
[2]   ALPHA-FETOPROTEIN-PRODUCING ADENOCARCINOMA OF THE URETER [J].
HOSOMI, M ;
SAGAWA, S ;
KOTOU, Y .
UROLOGIA INTERNATIONALIS, 1992, 48 (02) :226-227
[3]  
ISHIKURA H, 1986, CANCER, V58, P119, DOI 10.1002/1097-0142(19860701)58:1<119::AID-CNCR2820580121>3.0.CO
[4]  
2-U
[5]  
MATIASGUIU X, 1989, PATHOL RES PRACT, V185, P397, DOI 10.1016/S0344-0338(89)80022-6
[6]   VALUE OF SERUM TUMOR MARKERS IN STAGING AND PROGNOSIS OF GERM-CELL TUMORS OF TESTIS [J].
SCARDINO, PT ;
COX, HD ;
WALDMANN, TA ;
MCINTIRE, KR ;
MITTEMEYER, B ;
JAVADPOUR, N .
JOURNAL OF UROLOGY, 1977, 118 (06) :994-999
[7]  
SHIRAI T, 1976, CANCER, V38, P1661, DOI 10.1002/1097-0142(197610)38:4<1661::AID-CNCR2820380437>3.0.CO
[8]  
2-K
[9]  
VUGRIN D, 1985, CANCER, V55, P1874, DOI 10.1002/1097-0142(19850501)55:9<1874::AID-CNCR2820550905>3.0.CO
[10]  
2-J